SGS518

Thuốc Gốc

Small Molecule

SGS518, a novel antagonist for the 5HT6 subtype of the serotonin receptor, is being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS).

Cơ Chế Tác Dụng : SGS518, a novel antagonist for the 5HT6 subtype of the serotonin receptor, is being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS). SGS518 is a selective antagonist of the 5-Hydroxytryptamine-6 (5-HT6) serotonin receptor believed to act by enhancing transmission of chemicals in the brain.

Chỉ Định : Investigated for use/treatment in neurologic disorders and schizophrenia and schizoaffective disorders.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05042

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading